Literature DB >> 10566383

Tool support for authoring eligibility criteria for cancer trials.

D L Rubin1, J H Gennari, S Srinivas, A Yuen, H Kaizer, M A Musen, J S Silva.   

Abstract

A critical component of authoring new clinical trial protocols is assembling a set of eligibility criteria for patient enrollment. We found that clinical protocols in three different cancer domains can be categorized according to a set of clinical states that describe various clinical scenarios for that domain. Classifying protocols in this manner revealed similarities among the eligibility criteria and permitted some standardization of criteria based on clinical state. We have developed an eligibility criteria authoring tool which uses a standard set of eligibility criteria and a diagram of the clinical states to present the relevant eligibility criteria to the protocol author. We demonstrate our ideas with phase-3 protocols from breast cancer, prostate cancer, and non-small cell lung cancer. Based on measurements of redundancy and percentage coverage of criteria included in our tool, we conclude that our model reduces redundancy in the number of criteria needed to author multiple protocols, and it allows some eligibility criteria to be authored automatically based on the clinical state of interest for a protocol.

Entities:  

Mesh:

Year:  1999        PMID: 10566383      PMCID: PMC2232521     

Source DB:  PubMed          Journal:  Proc AMIA Symp        ISSN: 1531-605X


  3 in total

1.  Knowledge engineering for a clinical trial advice system: uncovering errors in protocol specification.

Authors:  M A Musen; J A Rohn; L M Fagan; E H Shortliffe
Journal:  Bull Cancer       Date:  1987       Impact factor: 1.276

2.  PROTEGE-II: computer support for development of intelligent systems from libraries of components.

Authors:  M A Musen; J H Gennari; H Eriksson; S W Tu; A R Puerta
Journal:  Medinfo       Date:  1995

3.  A methodology for determining patients' eligibility for clinical trials.

Authors:  S W Tu; C A Kemper; N M Lane; R W Carlson; M A Musen
Journal:  Methods Inf Med       Date:  1993-08       Impact factor: 2.176

  3 in total
  9 in total

1.  Design and implementation of a national clinical trials registry.

Authors:  A T McCray; N C Ide
Journal:  J Am Med Inform Assoc       Date:  2000 May-Jun       Impact factor: 4.497

2.  Knowledge representation and tool support for critiquing clinical trial protocols.

Authors:  D L Rubin; J Gennari; M A Musen
Journal:  Proc AMIA Symp       Date:  2000

3.  Enrolling patients into clinical trials faster using RealTime Recuiting.

Authors:  A J Butte; D A Weinstein; I S Kohane
Journal:  Proc AMIA Symp       Date:  2000

4.  Towards a common framework for clinical trials information systems.

Authors:  N C Salgado; A Gouveia-Oliveira
Journal:  Proc AMIA Symp       Date:  2000

5.  Cross-tool communication: from protocol authoring to eligibility determination.

Authors:  J H Gennari; D Sklar; J Silva
Journal:  Proc AMIA Symp       Date:  2001

Review 6.  Formal representation of eligibility criteria: a literature review.

Authors:  Chunhua Weng; Samson W Tu; Ida Sim; Rachel Richesson
Journal:  J Biomed Inform       Date:  2009-12-23       Impact factor: 6.317

7.  Finding appropriate clinical trials: evaluating encoded eligibility criteria with incomplete data.

Authors:  N Ash; O Ogunyemi; Q Zeng; L Ohno-Machado
Journal:  Proc AMIA Symp       Date:  2001

8.  Trial prospector: matching patients with cancer research studies using an automated and scalable approach.

Authors:  Satya S Sahoo; Shiqiang Tao; Andrew Parchman; Zhihui Luo; Licong Cui; Patrick Mergler; Robert Lanese; Jill S Barnholtz-Sloan; Neal J Meropol; Guo-Qiang Zhang
Journal:  Cancer Inform       Date:  2014-12-04

9.  Semantic categorization of Chinese eligibility criteria in clinical trials using machine learning methods.

Authors:  Hui Zong; Jinxuan Yang; Zeyu Zhang; Zuofeng Li; Xiaoyan Zhang
Journal:  BMC Med Inform Decis Mak       Date:  2021-04-15       Impact factor: 2.796

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.